HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 2,425-2,436 of 4,505
Drug study icon
CompletedNCT00761670

Efficacy Study on Cognitive Functions in Schizophrenic Patients

Official study title

Comparative Efficacy of Amisulpride vs Risperidone on Cognitive Functions in Patients With Chronic Schizophrenia

This study has finished and is no longer accepting participants.

In Budapest
SchizophreniaMedication studyAges 18–65
Countries
Hungary
Sponsor
Sanofi
Drug study icon
CompletedNCT02477670

Efficacy, Safety, and Tolerability of AVP-786 for Residual Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of AVP-786 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Cerritos
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT01668797

Efficacy, Safety, and Tolerability of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults With Schizophrenia

What is this study about?

Researchers compared Brexpiprazole and placebo to find out how the approaches affected psychotic symptoms in adults with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Anaheim
SchizophreniaMedication studyAges 18–65
Countries
United States, Colombia, Malaysia, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT00922272

Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative Symptoms

Official study title

A Phase 2, Multicenter Study With Open-label & Randomized Double-blind Placebo-controlled Withdrawal Phases to Evaluate the Efficacy, Safety, & Tolerability of SPD489 in Adults With Schizophrenia & Predominant Negative Symptoms Who Are Clinically Stable & Taking Stable Doses of Atypical Antipsychotic Medication

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
SchizophreniaMedication studyAges 18–55
Countries
United States
Sponsor
Shire
Drug study icon
CompletedNCT01488929

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

What is this study about?

This study evaluated the safety and effectiveness of TC-5619 for people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
SchizophreniaMedication studyAges 18–65
Countries
United States, Hungary, Romania, + 3 others
Sponsor
Targacept Inc.
Drug study icon
CompletedNCT01516424

Efficiency Study to Investigate Blonanserin in Treatment of Schizophrenia When Compared With Risperidone

What is this study about?

Researchers compared Blonanserin and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

Multiple locations, including Beijing
SchizophreniaMedication studyAges 18–64
Countries
China
Sponsor
Marubeni Pharmaceuticals (Suzhou) Co., Ltd.
Other study type icon
CompletedNCT00001921

Electrophysiology and Blood Flow in people with Schizophrenia and Their Siblings

Official study title

Integrating EEG/MEG and fMRI: Activity Correlation Between Frontal and Temporal Lobe Structures in Schizophrenic Patients, Their Siblings and Unrelated Normal Volunteers

This study has finished and is no longer accepting participants.

In Bethesda
SchizophreniaObservational studyAges 18–55
Countries
United States
Sponsor
National Institute of Mental Health (NIMH) (Government agency)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.